We have observed
15 EP applications
Lars Bo Kjerrumgaard
has served for within the last five+ years.
(We consider all applications which have an EP A1 publication dated after February 14, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
Pedal adaptor for a bicycle pedal
Novel galactoside inhibitors of galectins
Novel 3-triazolyl-galactoside inhibitors of galectins
NOVEL GALACTOSIDE INHIBITORS OF GALECTINS
GALACTOSIDE INHIBITOR OF GALECTIN-3 AND ITS USE FOR TREATING PULMONARY FIBROSIS
METHODS, COMPOSITIONS AND KITS FOR TREATING, MODULATING, OR PREVENTING OCULAR ANGIOGENESIS OR FIBROSIS IN A SUBJECT USING A GALECTIN PROTEIN INHIBITOR
SOLID ORAL DOSAGE FORM OF TESTOSTERONE DERIVATIVE
SOLID ORAL DOSAGE FORM OF IRINOTECAN FOR THE TREATMENT OF CANCER
GALACTOSIDE INHIBITORS FOR THE TREATMENT OF ALPHA-SYNUCLEINOPTHIES
NOVEL HYBRID GALACTOSIDE INHIBITOR OF GALECTINS
NOVEL GALACTOSIDE INHIBITOR OF GALECTINS
A SEALED OXYGEN-TIGHT COOKING DEVICE FOR FOOD
ALPHA-D-GALACTOSIDE INHIBITORS OF GALECTINS
DIAGNOSING PULMONARY FIBROSIS